Pristiq Extended-Release is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc.. The primary component is Desvenlafaxine Succinate.
| Product ID | 0008-1222_0c40d9ea-730a-42d8-abd1-5a1da444dfb6 |
| NDC | 0008-1222 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Pristiq Extended-Release |
| Generic Name | Desvenlafaxine Succinate |
| Dosage Form | Tablet, Extended Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2008-05-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021992 |
| Labeler Name | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. |
| Substance Name | DESVENLAFAXINE SUCCINATE |
| Active Ingredient Strength | 100 mg/1 |
| Pharm Classes | Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2008-05-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021992 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2014-03-18 |
| Marketing End Date | 2015-03-25 |
| Marketing Category | NDA |
| Application Number | NDA021992 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2008-05-01 |
| Marketing Category | NDA |
| Application Number | NDA021992 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2008-05-01 |
| Marketing Category | NDA |
| Application Number | NDA021992 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2008-05-01 |
| Marketing Category | NDA |
| Application Number | NDA021992 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2008-05-01 |
| Marketing Category | NDA |
| Application Number | NDA021992 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2014-03-18 |
| Marketing End Date | 2015-03-25 |
| Ingredient | Strength |
|---|---|
| DESVENLAFAXINE SUCCINATE | 100 mg/1 |
| SPL SET ID: | 0f43610c-f290-46ea-d186-4f998ed99fce |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 46708-540 | Desvenlafaxine | Desvenlafaxine Succinate |
| 46708-541 | Desvenlafaxine | Desvenlafaxine Succinate |
| 46708-542 | Desvenlafaxine | Desvenlafaxine Succinate |
| 50090-5274 | Desvenlafaxine | Desvenlafaxine Succinate |
| 50090-5293 | Desvenlafaxine | Desvenlafaxine Succinate |
| 51991-006 | Desvenlafaxine | Desvenlafaxine Succinate |
| 51991-311 | Desvenlafaxine | Desvenlafaxine Succinate |
| 51991-312 | Desvenlafaxine | Desvenlafaxine Succinate |
| 55700-577 | Desvenlafaxine | Desvenlafaxine Succinate |
| 50090-4069 | Desvenlafaxine Succinate | desvenlafaxine succinate |
| 59762-1210 | Desvenlafaxine Succinate | desvenlafaxine succinate |
| 0008-1210 | Pristiq | desvenlafaxine succinate |
| 0008-1211 | Pristiq | desvenlafaxine succinate |
| 0008-1222 | Pristiq | desvenlafaxine succinate |
| 35356-491 | Pristiq | desvenlafaxine succinate |
| 43063-262 | Pristiq | desvenlafaxine succinate |
| 55154-4230 | Pristiq | desvenlafaxine succinate |
| 55154-4235 | Pristiq | desvenlafaxine succinate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() PRISTIQ 88308904 5828994 Live/Registered |
Wyeth LLC 2019-02-20 |
![]() PRISTIQ 78541902 3477940 Live/Registered |
WYETH LLC 2005-01-04 |
![]() PRISTIQ 77200228 3521683 Live/Registered |
WYETH LLC 2007-06-07 |